Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

National Cancer Center Hospital East

Clinical trials sponsored by National Cancer Center Hospital East, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for tough colorectal cancer: Triple-Drug combo enters human trials Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Not yet finished but already full! 3 Completed 4

New hope for tough colorectal cancer: Triple-Drug combo enters human trials

Disease control Not yet recruiting

This study tests a combination of three drugs—S-531011, fruquintinib, and pembrolizumab—in people with advanced colorectal cancer that has not responded to standard treatments. The cancer type is called MSS or pMMR, which typically does not respond well to immunotherapy alone. Th…

Phase 1/2 • Sponsor: National Cancer Center Hospital East • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC